Lifeboat Foundation

Indian start-up Green Robot Machinery (GRoboMac) has developed a cotton picker with autonomous robotic arms, mounted on a semi-autonomous electric farm vehicle.

The robotic arms of the battery-operated machine are each capable of picking about 50 kgs cotton per day. That means that four arms, mounted on the vehicle, can pick about 200 kgs per day. High yielding farms can use additional arms, the company says.

A novel type of deep brain stimulation known as responsive deep brain stimulation helped improve symptoms in a woman with severe OCD, according to a new study.

Join us on Patreon! https://www.patreon.com/MichaelLustgartenPhD

Discount Links:
Telomere and Epigenetic Testing: https://trudiagnostic.com/?irclickid=U-s3Ii2r7xyIU-LSYLyQdQ6…M0&irgwc=1
Use Code: CONQUERAGING

Continue reading “HbA1c: What’s Optimal, What’s My Data?” »

Music for pain relief and anxiety. I think somewhere else I read it helps heal brain injuries.

Further, subject-preferred music appears to induce a superior effect in relieving pain. This can be approached by allowing participants to select the most pleasant music from a prespecified list of songs or listen to their favorite music during the study. Nevertheless, the richness of emotions, meanings, and associations involved when listening to favorite music is poorly understood, especially regarding pain relief.

About the study

Continue reading “Study finds pleasurable music and ‘chills’ predict music-induced hypoalgesia” »

When someone dies in the US, the vast majority of the time, their body is either embalmed, placed in a coffin, and buried in a cemetery, or cremated and the ashes returned to their loved ones in an urn — but those aren’t the only options.

A growing number of funeral directors, startups, and nonprofits are providing people with alternative ways to have their bodies honored after death — suggesting that the funeral landscape of tomorrow won’t be so binary.

Traditional burial and cremation has a cost for the environment, releasing chemicals into the ground or greenhouse gasses into the air, but a number of other funeral options are showing that death can be green.

Cancer patients receiving anthracycline chemotherapy have more than twice the risk of developing heart failure compared to their peers without cancer.1The ground-breaking RESILIENCE project aims to prevent heart failure in patients who need anthracyclines to treat their cancer.

International experts and patients from the project gathered yesterday at the European Heart House, home of the European Society of Cardiology (ESC), as a unique think tank to improve the healthcare and quality of life for patients with cancer.

It is estimated that four million Europeans are diagnosed with cancer every year.2 Anthracycline chemotherapy has a prominent role in treating many forms of cancer-for example, up to 70% of patients with lymphoma receive an anthracycline regimen. Currently, there is no therapy to prevent anthracycline cardiotoxicity.

“To our knowledge, ours is the first study to achieve communication by someone who has no remaining voluntary movement.” — Jonas Zimmermann, a Wyss Center neuroscientist. Watch it here: https://www.freethink.com/health/locked-in-syndrome Freethink.

A man with total locked-in syndrome has used a brain-computer interface to spell out sentences with his mind.

The Wistar Institute’s David B. Weiner and collaborators have engineered novel monoclonal antibodies that engage natural killer (NK) cells through a unique surface receptor that activates the immune system to fight against cancer.

In their publication titled, “Siglec-7 glyco-immune binding MAbs or NK cell engager biologics induce potent anti-tumor immunity against ovarian cancers,” published in Science Advances, the team demonstrates the preclinical feasibility of utilizing these new cancer immunotherapeutic approaches against diverse ovarian cancer types, including treatment-resistant and refractory ovarian cancers—alone or in combination with checkpoint inhibitor treatment.

The research started as a collaboration between Wistar’s Drs. Weiner and Mohamed Abdel-Mohsen, who were exploring the development of new glyco-signaling biologic tools that may be important in the fight against cancer.

Atlassian has discovered yet another critical vulnerability in its Confluence Data Center and Server collaboration and project management platform, and it’s urging customers to patch the problem immediately. The latest advisory by Atlassian describes CVE-2023–22518 as an improper authorization vulnerability that affects all versions of the on-premises versions of Confluence.

It is the second critical vulnerability reported by Atlassian in a month, tied to its widely used Confluence Data Center and Server platform and among numerous security issues from the company during the past year. The previous bulletin (CVE-2023–22515) revealed a vulnerability that could allow an attacker to create unauthorized Confluence administrator accounts, thereby gaining access to instances. That vulnerability had a severity level of 10 and was discovered initially by some customers who reported they may have been breached by it.

To date, Atlassian is not aware of any active exploits of the newest vulnerability, which has a severity level of 9.1., though the company issued a statement encouraging customers to apply the patch. “We have discovered that Confluence Data Center and Server customers are vulnerable to significant data loss if exploited by an unauthenticated attacker,” Atlassian CISO Bala Sathiamurthy warned in a statement. “Customers must take immediate action to protect their instances.”